Nick Saccomano joined SomaLogic in 2009. Nick obtained his degree Ph.D. in chemistry from Columbia University in 1984 under the direction of Professor Gilbert Stork. In 1984, he joined Pfizer Inc. as a research scientist in the CNS discovery group. Between 1985 and 1998 held several positions in this group including head of medicinal chemistry. During this time, Nick worked on or led many programs targeting psychiatric and neurological indications including depression, anxiety, psychosis, sleep, stroke, Parkinson's disease and Alzheimer's disease. In 1998, he was promoted to Vice President of discovery technology. In this role, Nick managed and developed a diverse set of enabling technologies used broadly across the drug discovery process within Pfizer. In 2004, Nick was promoted to Senior Vice President of Global Research Technology and Strategic Alliances. In 2008, he moved to Bend Research Inc as Chief Scientific Officer and is currently member of the Board of Directors of this organization.